RPB researchers are working to understand and prevent macular degeneration, to halt its progression, and to develop optical devices to offset vision loss.
Four new grantees received the Catalyst Awards for Innovative Research Approaches for AMD.
RPB and AUPO announce the 2018 recipient of the award focused on age-related macular degeneration.
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.
The model will allow researchers to better assess treatments for this hard-to-study cause of blindness.